Urgent.News

What's breaking now, across thousands of outlets.

Editions

Finance & Markets

UroGen Pharma Stock Falls 5% After Signing Deals With IntraGel Therapeutics

(RTTNews) - Shares of UroGen Pharma Ltd. (URGN) are falling about 5 percent in Thursday morning trading after the company entered into an equity investment agreement and a strategic Option and Research License Agreement with IntraGel Therapeutics.

We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.

Read the original at nasdaq.com →

More in Finance & Markets

More from Thursday 20 August →